Exhibit 99.1 News Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Contact: Caroline Monahan 843-740-2068 media@ingevity.com Investors: John E. Nypaver, Jr. 843-740-2002 investors@ingevity.com Ingevity reports second quarter 2024 financial results HIGHLIGHTS: • Net sales of $390.6 million, down 19% compared to prior year • Net loss of $283.7 million and diluted loss per share of $7.81 primarily due to a Performance Chemicals non-cash goodwill impairment charg ...

The addition of a new distribution partner in Europe devoted to Ingevity's Capa biodegradable thermoplastics allows the company to better service its customers in the region. Ultrapolymers' network of compounders and converters, as well as its technical competence and customer service, are consistent with Ingevity's growth strategy in Europe. Image Source: Zacks Investment Research Ingevity, in February 2019, completed the purchase of the Capa caprolactone division of Perstorp Holding AB for roughly $652.5 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...

For the quarter ended March 2024, Ingevity (NGVT) reported revenue of $340.1 million, down 13.4% over the same period last year. EPS came in at $0.52, compared to $1.09 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $319.85 million, representing a surprise of +6.33%. The company delivered an EPS surprise of +40.54%, with the consensus EPS estimate being $0.37.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Ingevity (NGVT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $1.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 40.54%. A quarter ago, it was expected that this company would post a loss of $0.13 per share when it actually produced earnings of $0.21, delivering a surprise of 261.54%.Over the last four quarters, the company has surp ...

Exhibit 99.1 News Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Contact: Caroline Monahan 843-740-2068 media@ingevity.com Investors: John E. Nypaver, Jr. 843-740-2002 investors@ingevity.com Ingevity reports first quarter 2024 financial results HIGHLIGHTS: (comparisons versus prior year period) The results and guidance in this release include non-GAAP financial measures. Refer to the section entitled "Use of non- GAAP financial measures" within this release ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-K ______________________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-375 ...

Financial Performance Summary - Full year net sales were up by 1.4% reaching $1,692.1 million compared to $1,668.3 million in the prior year[23] - Adjusted EBITDA for the full year declined by 12.3% to $396.8 million[23, 24] - Diluted adjusted EPS decreased by 34% to $3.94[23, 118] Segment Performance - Performance Materials' full year sales increased by 6.8% to $586.0 million[12] and segment EBITDA increased by 13.6% to $286.6 million[12] - Road Technologies' full year sales increased by over 53% due to increased technology adoption and the acquisition of Ozark road markings business, reaching $369.8 million[17, 31] - Advanced Polymer Technologies' full year sales decreased by 16.6% to $204.0 million[28] - Industrial Specialties' full year sales decreased by 16% to $532.3 million[31, 43] 2024 Guidance - The company expects revenue between $1.40 billion and $1.55 billion[19] - Adjusted EBITDA is projected to be between $365 million and $390 million[19] - Capital expenditures are estimated to be between $90 million and $110 million[19]

Exhibit 99.1 News Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Contact: Caroline Monahan 843-740-2068 media@ingevity.com Investors: John Nypaver 843-740-2002 investors@ingevity.com Ingevity reports fourth quarter and full year 2023 financial results Fourth Quarter (comparisons versus prior year period): Full Year (comparisons versus prior year period): Guidance: Company announces full year 2024 guidance for sales between $1.40 billion and $1.55 billion an ...

Financial Performance - Net sales decreased by 7.5% to $446.0 million in Q3 2023 compared to $482.0 million in Q3 2022 [31] - Adjusted EBITDA decreased by 20.1% to $110.4 million with a margin of 24.8% in Q3 2023, compared to $138.2 million with a margin of 28.7% in Q3 2022 [31] - Diluted adjusted EPS decreased by 42.1% to $1.21 in Q3 2023, compared to $2.09 in Q3 2022 [31] - Performance Chemicals segment EBITDA decreased by 62% due to higher CTO costs and weak demand, reaching $24.7 million with a margin of 9.6% [4, 53, 59] Segment Performance - Performance Materials net sales increased by 1.6% to $147.2 million, with segment EBITDA up by 21.7% to $74.5 million and a margin of 50.6% [45] - Industrial Specialties sales decreased by 30% due to lower volumes, with segment EBITDA flat at $11.2 million and a margin of 26.2% [14, 42] - Pavement Technologies sales increased by 47% due to pricing gains and the Ozark acquisition [61] - Advanced Polymer Technologies (APT) sales decreased by 4% to $256.0 million due to lower volumes, with segment EBITDA margin improving to 26.2% [13, 14] Strategic Initiatives and Outlook - The company is repositioning its Performance Chemicals business to focus on higher margin specialty products, expecting EBITDA margins to improve from mid-single digits to 15-20% [30, 50] - The company expects approximately $180 million of non-cash charges and $100 million in cash charges related to the repositioning, with the majority of non-cash and 50-60% of cash charges recognized by the end of the first half of 2024 [8, 70] - The company anticipates ~$25 million in combined savings from Q2 actions and the repositioning announcement [48] - The company reduced total global headcount by approximately 20% [17] - The company expects revenue between $1.6 and $1.7 billion, adjusted EBITDA between $375 and $390 million, capital expenditures between $95 and $105 million, and free cash flow between $75 and $85 million for the full year [47]